"Company","Parent Company","Penalty Amount","Subtraction From Penalty","Penalty Amount Adjusted For Eliminating Multiple Counting","Penalty Year","Penalty Date","Offense Group","Primary Offense","Secondary Offense","Description","Level of Government","Action Type","Agency","Civil/Criminal","Prosecution Agreement","Court","Case ID","Private Litigation Case Title","Lawsuit Resolution","Facility State","City","Address","Zip","NAICS Code","NAICS Translation","HQ Country of Parent","HQ State of Parent","Ownership Structure","Parent Company Stock Ticker","Major Industry of Parent","Specific Industry of Parent","Info Source","Notes"
"Ranbaxy USA Inc.","Sun Pharmaceuticals","$500,000,000","$0","$500,000,000","2013","20130513","safety-related offenses","drug or medical equipment safety violation","","In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA Inc. , a subsidiary of Indian generic pharmaceutical manufacturer Ranbaxy Laboratories Limited, pleaded guilty to felony charges relating to the manufacture and distribution of certain adulterated drugs made at two of Ranbaxy's manufacturing facilities in India. Ranbaxy also agreed to pay a criminal fine and forfeiture totaling $150 million and to settle civil claims under the False Claims Act and related State laws for $350 million.","federal","agency action","Food and Drug Administration referral to the Justice Department","civil and criminal","","","","","","","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","http://www.justice.gov/opa/pr/generic-drug-manufacturer-ranbaxy-pleads-guilty-and-agrees-pay-500-million-resolve-false",""
"Ranbaxy","Sun Pharmaceuticals","$266,729,715","$266,729,715","$0","2013","20130513","safety-related offenses","drug or medical equipment safety violation","","Ranbaxy paid $266 million to resolve multistate litigation alleging that it sold generic drugs that lacked necessary active ingredients due to poor quality control standards to customers including state Medicaid programs. This was part of a larger $500 million civil and criminal settlement that involved the federal government; see the Violation Tracker entry at https://violationtracker.goodjobsfirst.org/violation-tracker/-ranbaxy-usa-inc","state","agency action","Multistate Attorneys General Case","civil","","","","","","","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20150906073322/http://www.ag.ny.gov/press-release/ag-schneiderman-announces-pharmaceutical-giant-pay-500-million-penalty-selling-drugs",""
"Ranbaxy","Sun Pharmaceuticals","$5,000,000","$0","$5,000,000","2013","20131118","government-contracting-related offenses","False Claims Act and related","","The Louisiana Attorney General's Office announced that it had obtained a total of $88 million in settlements from 25 pharmaceutical companies to resolve allegations they overcharged the state's Medicaid program.","state","agency action","Louisiana Attorney General","civil","","","","","","Louisiana","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20131206104321/http://www.ag.state.la.us/Article.aspx?articleID=788&catID=2",""
"Ranbaxy Laboratories","Sun Pharmaceuticals","$2,300,000","$0","$2,300,000","2014","20140708","safety-related offenses","drug or medical equipment safety violation","","settlement of allegations that company produced adulterated drugs","state","agency action","Oregon Attorney General","civil","","","","","","Oregon","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://www.doj.state.or.us/media-home/news-media-releases/oregon-settles-with-ranbaxy-for-2-3-million/",""
"Ranbaxy Pharmaceuticals, Inc.","Sun Pharmaceuticals","$150,000","$0","$150,000","2014","20140219","competition-related offenses","price-fixing or anti-competitive practices","","","state","agency action","New York Attorney General","civil","","","","","","New York","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://web.archive.org/web/20190827225126/https://ag.ny.gov/press-release/ag-schneiderman-announces-settlement-generic-pharmaceutical-companies-entering",""
"Ranbaxy Pharmaceuticals, Inc. et al.","Sun Pharmaceuticals","$17,875,000","$0","$17,875,000","2014","20141016","government-contracting-related offenses","False Claims Act and related","","Falsification of wholesale drug price reporting. Federal government shared in the settlement. Penalty amount listed here is state portion only.","state","agency action","Texas Attorney General","civil","","","","","","Texas","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","Attorney General Abbott Recovers $39.75 Million for State ofTexas, U.S. Medicaid Program, Targeted News Service, October 16, 2014 (via Nexis).",""
"DUSA Pharmaceuticals, Inc.","Sun Pharmaceuticals","$20,750,000","$0","$20,750,000","2020","20200824","government-contracting-related offenses","False Claims Act and related","","Massachusetts-based DUSA Pharmaceuticals, Inc., a subsidiary of Sun Pharmaceutical Industries, Inc., agreed to pay the United States $20.75 million to resolve allegations that it caused physicians to submit false claims to Medicare and the Federal Employee Health Benefit Program by knowingly promoting an administration process for the drug Levulan Kerastick that contradicted the product instructions approved by the U.S. Food and Drug Administration and was unsupported by sufficient clinical evidence.  ","federal","agency action","Justice Department Civil Division","civil","","","","","","Massachusetts","","","","","","India","","publicly traded","","pharmaceuticals","pharmaceuticals","https://www.justice.gov/opa/pr/dusa-pharmaceuticals-pay-us-2075-million-settle-false-claims-act-allegations-relating",""
"SUN PHARMACEUTICAL INDUSTRIES, INC.","Sun Pharmaceuticals","$9,620","$0","$9,620","2016","20160308","safety-related offenses","workplace safety or health violation","","","federal","agency action","Occupational Safety & Health Administration","civil","","","","","","New Jersey","CRANBURY","270 PROSPECT PLAINS RD.","08512","325412","325412: Pharmaceutical Preparation Manufacturing","India","","publicly traded","","pharmaceuticals","pharmaceuticals","Extracted from a download of OSHA's Enforcment Data downloaded on 3/02/2022, available at https://enforcedata.dol.gov/views/data_catalogs.php",""
